A review of basic to clinical studies of irreversible electroporation therapy

Chunlan Jiang, Rafael V. Davalos, John C Bischof

Research output: Contribution to journalReview article

131 Citations (Scopus)

Abstract

The use of irreversible electroporation (IRE) for cancer treatment has increased sharply over the past decade. As a nonthermal therapy, IRE offers several potential benefits over other focal therapies, which include 1) short treatment delivery time, 2) reduced collateral thermal injury, and 3) the ability to treat tumors adjacent to major blood vessels. These advantages have stimulated widespread interest in basic through clinical studies of IRE. For instance, many in vitro and in vivo studies now identify treatment planning protocols (IRE threshold, pulse parameters, etc.), electrode delivery (electrode design, placement, intraoperative imaging methods, etc.), injury evaluation (methods and timing), and treatment efficacy in different cancer models. Therefore, this study reviews the in vitro, translational, and clinical studies of IRE cancer therapy based on major experimental studies particularly within the past decade. Further, this study provides organized data and facts to assist further research, optimization, and clinical applications of IRE.

Original languageEnglish (US)
Article number6949110
Pages (from-to)4-20
Number of pages17
JournalIEEE Transactions on Biomedical Engineering
Volume62
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Electrodes
Oncology
Blood vessels
Tumors
Imaging techniques
Planning
Hot Temperature

Keywords

  • Animal
  • Clinical
  • Enhancement
  • In vitro
  • Irreversible electroporation

Cite this

A review of basic to clinical studies of irreversible electroporation therapy. / Jiang, Chunlan; Davalos, Rafael V.; Bischof, John C.

In: IEEE Transactions on Biomedical Engineering, Vol. 62, No. 1, 6949110, 01.01.2015, p. 4-20.

Research output: Contribution to journalReview article

@article{9fd8c56a54904c10b1e611c1da09d8cc,
title = "A review of basic to clinical studies of irreversible electroporation therapy",
abstract = "The use of irreversible electroporation (IRE) for cancer treatment has increased sharply over the past decade. As a nonthermal therapy, IRE offers several potential benefits over other focal therapies, which include 1) short treatment delivery time, 2) reduced collateral thermal injury, and 3) the ability to treat tumors adjacent to major blood vessels. These advantages have stimulated widespread interest in basic through clinical studies of IRE. For instance, many in vitro and in vivo studies now identify treatment planning protocols (IRE threshold, pulse parameters, etc.), electrode delivery (electrode design, placement, intraoperative imaging methods, etc.), injury evaluation (methods and timing), and treatment efficacy in different cancer models. Therefore, this study reviews the in vitro, translational, and clinical studies of IRE cancer therapy based on major experimental studies particularly within the past decade. Further, this study provides organized data and facts to assist further research, optimization, and clinical applications of IRE.",
keywords = "Animal, Clinical, Enhancement, In vitro, Irreversible electroporation",
author = "Chunlan Jiang and Davalos, {Rafael V.} and Bischof, {John C}",
year = "2015",
month = "1",
day = "1",
doi = "10.1109/TBME.2014.2367543",
language = "English (US)",
volume = "62",
pages = "4--20",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "1",

}

TY - JOUR

T1 - A review of basic to clinical studies of irreversible electroporation therapy

AU - Jiang, Chunlan

AU - Davalos, Rafael V.

AU - Bischof, John C

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The use of irreversible electroporation (IRE) for cancer treatment has increased sharply over the past decade. As a nonthermal therapy, IRE offers several potential benefits over other focal therapies, which include 1) short treatment delivery time, 2) reduced collateral thermal injury, and 3) the ability to treat tumors adjacent to major blood vessels. These advantages have stimulated widespread interest in basic through clinical studies of IRE. For instance, many in vitro and in vivo studies now identify treatment planning protocols (IRE threshold, pulse parameters, etc.), electrode delivery (electrode design, placement, intraoperative imaging methods, etc.), injury evaluation (methods and timing), and treatment efficacy in different cancer models. Therefore, this study reviews the in vitro, translational, and clinical studies of IRE cancer therapy based on major experimental studies particularly within the past decade. Further, this study provides organized data and facts to assist further research, optimization, and clinical applications of IRE.

AB - The use of irreversible electroporation (IRE) for cancer treatment has increased sharply over the past decade. As a nonthermal therapy, IRE offers several potential benefits over other focal therapies, which include 1) short treatment delivery time, 2) reduced collateral thermal injury, and 3) the ability to treat tumors adjacent to major blood vessels. These advantages have stimulated widespread interest in basic through clinical studies of IRE. For instance, many in vitro and in vivo studies now identify treatment planning protocols (IRE threshold, pulse parameters, etc.), electrode delivery (electrode design, placement, intraoperative imaging methods, etc.), injury evaluation (methods and timing), and treatment efficacy in different cancer models. Therefore, this study reviews the in vitro, translational, and clinical studies of IRE cancer therapy based on major experimental studies particularly within the past decade. Further, this study provides organized data and facts to assist further research, optimization, and clinical applications of IRE.

KW - Animal

KW - Clinical

KW - Enhancement

KW - In vitro

KW - Irreversible electroporation

UR - http://www.scopus.com/inward/record.url?scp=84919936112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919936112&partnerID=8YFLogxK

U2 - 10.1109/TBME.2014.2367543

DO - 10.1109/TBME.2014.2367543

M3 - Review article

VL - 62

SP - 4

EP - 20

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 1

M1 - 6949110

ER -